Strategies for Establishing and Utilizing a Secure Cell Line Expressing Each Gaussia Luciferase and Firefly Luciferase to Display screen for Endoplasmic Reticulum Stress.
- Coiled-coil area containing 67 (CCDC67) gene is a tumor suppressor gene that displays a major inhibitory impact on quite a lot of tumors. Our earlier research demonstrated that the upregulation of CCDC67 gene in TPC-1 cells inhibited cell proliferation, migration and invasion, and promoted apoptosis in vitro.
- Nevertheless, because of the lack of a appropriate cell software, these outcomes weren’t validated in vivo. Within the current research, a thyroid most cancers cell line with steady expression of CCDC67 and luciferase reporter genes was generated and recognized. Firstly, cDNA clones of the CCDC67 gene had been obtained by reverse transcription utilizing a custom-designed primer.
- The outcomes of subsequent electrophoresis evaluation and sequencing revealed that the cDNA clones of CCDC67 gene had been obtained efficiently, with a size of 1,862 bp. The lentiviral vectors, containing the CCDC67, luciferase reporter and puromycin acetyltransferase genes, had been co-transfected with two plasmids that encode lentiviral structural proteins and envelope proteins into 293T cells.
AFAP1L2 3’UTR Luciferase Secure Cell Line
- Following ultracentrifugation, the titer of lentivirus was decided by ELISA to be 5.0×108 TU/ml. The constructed lentiviral vector was used to transfect TPC-1 thyroid most cancers cells, and stabilization was achieved by puromycin screening. The expression of CCDC67 gene, luciferase exercise and tumorigenic means of the generated cell line had been detected.
- Reverse transcription-qPCR outcomes demonstrated that the expression ranges of CCDC67 gene in TPC-1 cells following transfection had been elevated 194,46.782-fold in contrast with these within the unfavourable management group (P<0.01).
- A better fluorescence depth was detected within the generated cell line, whereas no detectable fluorescence was noticed in untransfected TPC-1 cells. The tumorigenic means of TPC-1-Luc-Puromycin-CCDC67 cells was verified by bioluminescence imaging and histopathological evaluation utilizing a pulmonary metastasis mannequin.
Human Angiotensinogen (AGT) ELISA Equipment | Mouse Angiotensinogen (AGT) ELISA Equipment
- These outcomes demonstrated {that a} thyroid most cancers cell line with steady expression of CCDC67 and luciferase reporter genes was generated efficiently. The TPC-1-Luc-Puromycin-CCDC67 cell line could also be a useful software for additional analysis on CCDC67 in vivo.
![]() Serpine2 3'UTR Luciferase Stable Cell Line |
|||
TU220187 | ABM | 1.0 ml | Ask for price |
![]() Serpine2 3'UTR GFP Stable Cell Line |
|||
TU168642 | ABM | 1.0 ml | Ask for price |
![]() Serpine2 3'UTR GFP Stable Cell Line |
|||
TU270187 | ABM | 1.0 ml | Ask for price |
![]() SERPINE2 3'UTR GFP Stable Cell Line |
|||
TU072972 | ABM | 1.0 ml | EUR 1394 |
![]() A1CF 3'UTR Luciferase Stable Cell Line |
|||
TU000003 | ABM | 1.0 ml | EUR 1394 |
![]() A2LD1 3'UTR Luciferase Stable Cell Line |
|||
TU000004 | ABM | 1.0 ml | EUR 1394 |
![]() A2M 3'UTR Luciferase Stable Cell Line |
|||
TU000005 | ABM | 1.0 ml | EUR 1394 |
![]() A2ML1 3'UTR Luciferase Stable Cell Line |
|||
TU000006 | ABM | 1.0 ml | EUR 1394 |
![]() A2MP1 3'UTR Luciferase Stable Cell Line |
|||
TU000007 | ABM | 1.0 ml | EUR 2333 |
![]() A3GALT2 3'UTR Luciferase Stable Cell Line |
|||
TU000008 | ABM | 1.0 ml | EUR 2333 |
![]() A4GALT 3'UTR Luciferase Stable Cell Line |
|||
TU000009 | ABM | 1.0 ml | EUR 1394 |
![]() A4GNT 3'UTR Luciferase Stable Cell Line |
|||
TU000010 | ABM | 1.0 ml | EUR 1394 |
![]() AAAS 3'UTR Luciferase Stable Cell Line |
|||
TU000011 | ABM | 1.0 ml | EUR 1394 |
![]() AACP 3'UTR Luciferase Stable Cell Line |
|||
TU000012 | ABM | 1.0 ml | EUR 2333 |
![]() AACS 3'UTR Luciferase Stable Cell Line |
|||
TU000013 | ABM | 1.0 ml | EUR 1394 |
![]() AACSL 3'UTR Luciferase Stable Cell Line |
|||
TU000014 | ABM | 1.0 ml | EUR 2333 |
![]() AADAC 3'UTR Luciferase Stable Cell Line |
|||
TU000015 | ABM | 1.0 ml | EUR 1394 |
![]() AADACL2 3'UTR Luciferase Stable Cell Line |
|||
TU000016 | ABM | 1.0 ml | EUR 2333 |
![]() AADACL3 3'UTR Luciferase Stable Cell Line |
|||
TU000017 | ABM | 1.0 ml | EUR 1521 |
![]() AADACL4 3'UTR Luciferase Stable Cell Line |
|||
TU000018 | ABM | 1.0 ml | EUR 1394 |
![]() AADAT 3'UTR Luciferase Stable Cell Line |
|||
TU000019 | ABM | 1.0 ml | EUR 1394 |
![]() AAGAB 3'UTR Luciferase Stable Cell Line |
|||
TU000020 | ABM | 1.0 ml | EUR 2333 |
![]() AAK1 3'UTR Luciferase Stable Cell Line |
|||
TU000021 | ABM | 1.0 ml | EUR 1521 |
![]() AAMP 3'UTR Luciferase Stable Cell Line |
|||
TU000022 | ABM | 1.0 ml | EUR 1394 |
![]() AANAT 3'UTR Luciferase Stable Cell Line |
|||
TU000023 | ABM | 1.0 ml | EUR 1394 |
![]() AARS 3'UTR Luciferase Stable Cell Line |
|||
TU000024 | ABM | 1.0 ml | EUR 1394 |
![]() AARS2 3'UTR Luciferase Stable Cell Line |
|||
TU000025 | ABM | 1.0 ml | EUR 1394 |
![]() AARSD1 3'UTR Luciferase Stable Cell Line |
|||
TU000026 | ABM | 1.0 ml | EUR 1394 |
![]() AASDH 3'UTR Luciferase Stable Cell Line |
|||
TU000027 | ABM | 1.0 ml | EUR 1521 |
![]() AASDHPPT 3'UTR Luciferase Stable Cell Line |
|||
TU000028 | ABM | 1.0 ml | EUR 1521 |
![]() AASS 3'UTR Luciferase Stable Cell Line |
|||
TU000029 | ABM | 1.0 ml | EUR 2333 |
![]() AATF 3'UTR Luciferase Stable Cell Line |
|||
TU000030 | ABM | 1.0 ml | EUR 1394 |
![]() AATK 3'UTR Luciferase Stable Cell Line |
|||
TU000031 | ABM | 1.0 ml | EUR 1521 |
![]() ABAT 3'UTR Luciferase Stable Cell Line |
|||
TU000033 | ABM | 1.0 ml | EUR 2333 |
![]() ABCA1 3'UTR Luciferase Stable Cell Line |
|||
TU000034 | ABM | 1.0 ml | EUR 2333 |
![]() ABCA2 3'UTR Luciferase Stable Cell Line |
|||
TU000035 | ABM | 1.0 ml | EUR 4617 |
![]() ABCA3 3'UTR Luciferase Stable Cell Line |
|||
TU000036 | ABM | 1.0 ml | EUR 4617 |
![]() ABCA4 3'UTR Luciferase Stable Cell Line |
|||
TU000037 | ABM | 1.0 ml | EUR 1394 |
![]() ABCA5 3'UTR Luciferase Stable Cell Line |
|||
TU000038 | ABM | 1.0 ml | EUR 2333 |
![]() ABCA6 3'UTR Luciferase Stable Cell Line |
|||
TU000039 | ABM | 1.0 ml | EUR 2333 |
![]() ABCA7 3'UTR Luciferase Stable Cell Line |
|||
TU000040 | ABM | 1.0 ml | EUR 1394 |
![]() ABCA8 3'UTR Luciferase Stable Cell Line |
|||
TU000041 | ABM | 1.0 ml | EUR 2333 |
![]() ABCA9 3'UTR Luciferase Stable Cell Line |
|||
TU000042 | ABM | 1.0 ml | EUR 1521 |
![]() ABCA10 3'UTR Luciferase Stable Cell Line |
|||
TU000043 | ABM | 1.0 ml | EUR 2333 |
![]() ABCA12 3'UTR Luciferase Stable Cell Line |
|||
TU000045 | ABM | 1.0 ml | EUR 1394 |
![]() ABCA13 3'UTR Luciferase Stable Cell Line |
|||
TU000046 | ABM | 1.0 ml | EUR 2333 |
![]() ABCB1 3'UTR Luciferase Stable Cell Line |
|||
TU000048 | ABM | 1.0 ml | EUR 2333 |
![]() ABCB4 3'UTR Luciferase Stable Cell Line |
|||
TU000049 | ABM | 1.0 ml | EUR 1394 |
![]() ABCB5 3'UTR Luciferase Stable Cell Line |
|||
TU000050 | ABM | 1.0 ml | EUR 1394 |
![]() ABCB6 3'UTR Luciferase Stable Cell Line |
|||
TU000051 | ABM | 1.0 ml | EUR 1521 |
![]() ABCB7 3'UTR Luciferase Stable Cell Line |
|||
TU000052 | ABM | 1.0 ml | EUR 1521 |
![]() ABCB8 3'UTR Luciferase Stable Cell Line |
|||
TU000053 | ABM | 1.0 ml | EUR 2333 |
![]() ABCB9 3'UTR Luciferase Stable Cell Line |
|||
TU000054 | ABM | 1.0 ml | EUR 1394 |
![]() ABCB10 3'UTR Luciferase Stable Cell Line |
|||
TU000055 | ABM | 1.0 ml | EUR 1521 |
![]() ABCB10P1 3'UTR Luciferase Stable Cell Line |
|||
TU000056 | ABM | 1.0 ml | EUR 2333 |
![]() ABCB10P2 3'UTR Luciferase Stable Cell Line |
|||
TU000057 | ABM | 1.0 ml | EUR 2333 |
![]() ABCB10P3 3'UTR Luciferase Stable Cell Line |
|||
TU000058 | ABM | 1.0 ml | EUR 2333 |
![]() ABCB10P4 3'UTR Luciferase Stable Cell Line |
|||
TU000059 | ABM | 1.0 ml | EUR 2333 |
![]() ABCB11 3'UTR Luciferase Stable Cell Line |
|||
TU000060 | ABM | 1.0 ml | EUR 1521 |
![]() ABCC1 3'UTR Luciferase Stable Cell Line |
|||
TU000061 | ABM | 1.0 ml | EUR 1521 |
Hepa1-6-FLuc cell line with the steady expression of firefly luciferase retains its main properties with promising bioluminescence imaging means.
- Dependable animal fashions are required for the in vivo research of the molecular mechanisms and results of chemotherapeutic medicine in hepatocarcinoma.
- In vivo tracing methods based mostly on firefly luciferase (FLuc) could optimize the non-invasive monitoring of experimental animals. The current research established a murine Hepa1-6-FLuc cell line that stably expressed a retrovirus-delivered FLuc protein gene.
Rat Angiotensinogen (AGT) ELISA Equipment | Mouse Angiotensinogen (AGT) ELISA Equipment
- The cell morphology, proliferation, migration and invasion means of Hepa1-6-FLuc cells had been the identical as that of the Hepa1-6 cells, and thus is appropriate to exchange Hepa1-6 cells within the building of hepatocarcinoma animal fashions. No variations in subcutaneous tumor mass and its pathomorphology from implanted Hepa1-6-FLuc cells had been noticed in contrast with Hepa1-6 management tumors.
![]() Human Angiotensinogen (AGT) ELISA Kit |
|||
RD-AGT-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 418 |
![]() Human Angiotensinogen (AGT) ELISA Kit |
|||
RD-AGT-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 575 |
![]() Mouse Angiotensinogen (AGT) ELISA Kit |
|||
RD-AGT-Mu-48Tests | Reddot Biotech | 48 Tests | EUR 429 |
![]() Mouse Angiotensinogen (AGT) ELISA Kit |
|||
RD-AGT-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 591 |
![]() Rat Angiotensinogen (AGT) ELISA Kit |
|||
RD-AGT-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 450 |
![]() Rat Angiotensinogen (AGT) ELISA Kit |
|||
RD-AGT-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 622 |
![]() Human Angiotensinogen (AGT) ELISA Kit |
|||
RDR-AGT-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 436 |
![]() Human Angiotensinogen (AGT) ELISA Kit |
|||
RDR-AGT-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 601 |
![]() Mouse Angiotensinogen (AGT) ELISA Kit |
|||
RDR-AGT-Mu-48Tests | Reddot Biotech | 48 Tests | EUR 447 |
![]() Mouse Angiotensinogen (AGT) ELISA Kit |
|||
RDR-AGT-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 618 |
![]() Rat Angiotensinogen (AGT) ELISA Kit |
|||
RDR-AGT-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 470 |
![]() Rat Angiotensinogen (AGT) ELISA Kit |
|||
RDR-AGT-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 651 |
![]() AGT antibody |
|||
70R-6214 | Fitzgerald | 50 ug | EUR 467 |
Description: Rabbit polyclonal AGT antibody |
![]() AGT Antibody |
|||
BF0069 | Affbiotech | 200ul | EUR 376 |
Description: AGT antibody detects endogenous levels of total AGT. |
![]() AGT Antibody |
|||
ABD7976 | Lifescience Market | 100 ug | EUR 438 |
![]() AGT Antibody |
|||
ABD8022 | Lifescience Market | 100 ug | EUR 438 |
![]() AGT Antibody |
|||
ABD8094 | Lifescience Market | 100 ug | EUR 438 |
![]() AGT antibody |
|||
70R-14180 | Fitzgerald | 100 ug | EUR 322 |
Description: Affinity purified Rabbit polyclonal AGT antibody |
![]() AGT antibody |
|||
70R-15631 | Fitzgerald | 50 ul | EUR 435 |
Description: Rabbit polyclonal AGT antibody |
![]() AGT antibody |
|||
10R-1811 | Fitzgerald | 100 ul | EUR 403 |
Description: Mouse monoclonal AGT antibody |
![]() AGT Antibody |
|||
DF7976 | Affbiotech | 200ul | EUR 304 |
Description: AGT Antibody detects endogenous levels of total AGT. |
![]() AGT Antibody |
|||
1-CSB-PA693559 | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:1000-1:5000, IHC:1:25-1:100 |
![]() AGT Antibody |
|||
1-CSB-PA090852 | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000 |
![]() AGT Antibody |
|||
1-CSB-PA10079A0Rb | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF, IP; Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:400, IF:1:50-1:200, IP:1:200-1:2000 |
![]() AGT Antibody |
|||
1-CSB-PA173097 | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA;ELISA:1:1000-1:2000 |
![]() AGT Antibody |
|||
1-CSB-PA446811 | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
![]() AGT Antibody |
|||
1-CSB-PA281661 | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000 |
![]() AGT Antibody |
|||
1-CSB-PA959270 | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
![]() AGT Antibody |
|||
1-CSB-PA982509 | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:1000-1:2000, WB:1:200-1:1000 |
![]() AGT Antibody |
|||
1-CSB-PA001463EA01HU | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:5000, IHC:1:500-1:1000 |
![]() AGT Antibody |
|||
1-CSB-PA001463ESR1HU | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
![]() AGT Antibody |
|||
1-CSB-PA001463ESR2HU | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200, IF:1:50-1:200 |
![]() AGT Antibody |
|||
1-CSB-PA001463GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
![]() AGT Antibody |
|||
36739-100ul | SAB | 100ul | EUR 252 |
![]() AGT antibody |
|||
38789-100ul | SAB | 100ul | EUR 252 |
![]() AGT Antibody (CT) |
|||
6708-100 | Biovision | EUR 316 |
![]() AGT Antibody (NT) |
|||
6709-100 | Biovision | EUR 316 |
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx301357 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx128540 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx110982 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx101137 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx101138 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx101139 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx101140 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
abx010360-100ul | Abbexa | 100 ul | EUR 411 |
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx004798 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
abx033720-400ul | Abbexa | 400 ul | EUR 523 |
![]() Angiotensinogen (AGT) Antibody |
|||
abx033720-80l | Abbexa | 80 µl | EUR 286 |
![]() Angiotensinogen (AGT) Antibody |
|||
abx033721-400ul | Abbexa | 400 ul | EUR 523 |
![]() Angiotensinogen (AGT) Antibody |
|||
abx033721-80l | Abbexa | 80 µl | EUR 286 |
![]() AGT Polyclonal Antibody |
|||
A50656 | EpiGentek | 100 µg | EUR 570.55 |
Description: The best epigenetics products |
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx171240 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx320213 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx322250 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
abx230393-100ug | Abbexa | 100 ug | EUR 509 |
![]() Angiotensinogen (AGT) Antibody |
|||
abx230394-100ug | Abbexa | 100 ug | EUR 481 |
![]() Angiotensinogen (AGT) Antibody |
|||
abx230395-100ug | Abbexa | 100 ug | EUR 481 |
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx339646 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx241726 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx241946 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx241947 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx242324 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx214416 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx175400 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody |
|||
20-abx211344 | Abbexa |
|
|
![]() Anti-AGT antibody |
|||
STJ28201 | St John's Laboratory | 100 µl | EUR 277 |
Description: The protein encoded by this gene, pre-angiotensinogen or angiotensinogen precursor, is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure and in the pathogenesis of essential hypertension and preeclampsia. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease. |
![]() Anti-AGT antibody |
|||
STJ97818 | St John's Laboratory | 100 µl | EUR 234 |
Description: Mouse monoclonal to AGT. |
![]() Anti-AGT antibody |
|||
STJ118098 | St John's Laboratory | 100 µl | EUR 277 |
![]() AGT Conjugated Antibody |
|||
C36739 | SAB | 100ul | EUR 397 |
![]() AGT Conjugated Antibody |
|||
C38789 | SAB | 100ul | EUR 397 |
![]() aGT/ Rat aGT ELISA Kit |
|||
ELA-E0797r | Lifescience Market | 96 Tests | EUR 886 |
![]() Agt/ Rat Agt ELISA Kit |
|||
ELI-02702r | Lifescience Market | 96 Tests | EUR 886 |
![]() AGT siRNA |
|||
20-abx907049 | Abbexa |
|
|
![]() AGT siRNA |
|||
20-abx907050 | Abbexa |
|
|
![]() AGT Antibody, HRP conjugated |
|||
1-CSB-PA10079B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
![]() AGT Antibody, FITC conjugated |
|||
1-CSB-PA10079C0Rb | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
![]() AGT Antibody, Biotin conjugated |
|||
1-CSB-PA10079D0Rb | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
![]() AGT Antibody, HRP conjugated |
|||
1-CSB-PA001463EB01HU | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
![]() AGT Antibody, FITC conjugated |
|||
1-CSB-PA001463EC01HU | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
![]() AGT Antibody, Biotin conjugated |
|||
1-CSB-PA001463ED01HU | Cusabio |
|
|
Description: A polyclonal antibody against AGT. Recognizes AGT from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
![]() Angiotensinogen (AGT) Antibody (HRP) |
|||
20-abx306453 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody (FITC) |
|||
20-abx306454 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody (Biotin) |
|||
20-abx306455 | Abbexa |
|
|
![]() Anti-Angiotensinogen/AGT Antibody |
|||
PA1643 | BosterBio | 100ug/vial | EUR 294 |
![]() Anti-Angiotensinogen/AGT Antibody |
|||
A02103-1 | BosterBio | 100ug/vial | EUR 334 |
![]() Angiotensinogen (AGT) Antibody Pair |
|||
20-abx370425 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody Pair |
|||
20-abx370604 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody (FITC) |
|||
20-abx273972 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody (FITC) |
|||
20-abx274115 | Abbexa |
|
|
![]() Angiotensinogen (AGT) Antibody (Biotin) |
|||
20-abx272741 | Abbexa |
|
|
- Bioluminescence imaging indicated that the Luc sign of the Hepa1-6-FLuc cells was constantly strengthened with will increase in tumor mass; nonetheless, the Luc sign of Hepa1-6-AdFLuc turned weaker and finally disappeared throughout tumor improvement.
- Subsequently, in contrast with the transient expression by adenovirus, steady expression of the FLuc gene in Hepa1-6 cells could higher replicate cell proliferation and survival in vivo, and supply a dependable supply for the institution of hepatocarcinoma fashions.
- Bioluminescent tumor cell strains are experimental instruments of main significance for most cancers investigation, particularly imaging of tumors in xenografted animals. Secure expression of exogenous luciferase in tumor cells mixed to systemic injection of luciferin supplies a wonderful sign/background ratio for exterior optical imaging. Subsequently, there’s a have to rationalize and pace up the manufacturing of luciferase-positive tumor cell strains consultant of a number of tumor phenotypes.